Literature DB >> 7758147

Differential expression of nuclear HMG1, HMG2 proteins and H1(zero) histone in various blood cells.

P Cabart1, I Kalousek, D Jandová, Z Hrkal.   

Abstract

Changes in the levels of chromosomal high-mobility group proteins HMG1, HMG2 and histone H1 zero were investigated in blood cells of various types, proliferation activity and stage of differentiation. The relative amounts of proteins HMG1, HMG2 and histone H1 zero were evaluated densitometrically by SDS-PAGE of 5 per cent w/v perchloric acid extracts of blood cells. Concerning the HMG1 and HMG2, the main conclusions were: the expression of these HMG proteins was higher in malignant cells, namely leukemia cell lines, then in lymphocytes or granulocytes and the distribution of HMG1 and HMG2 was highly cell-specific. In comparison with lymphoid cells, the levels of HMG1/2 were higher in myeloid cells. The results revealed that in myeloid cells HMG2 prevails over HMG1. There was no direct correlation between HMG1/2 expression and proliferation activity. The levels of HMG1/2 did not depend on the transcription of chromatin either. However, there was some connection between irreversibly differentiated nonproliferating cells and a loss of HMG1/2 proteins. Reversibly differentiated leukemic cells retain their HMG1/2 levels. Similarly to HMG1/2,H1 zero showed a strong cell specificity. The level of H1 zero was different in the various blood cell types. As compared with lymphoid cells, the level of H1 zero was several-fold higher in myeloid cells, regardless of whether they were normal or malignant. Moreover, there was an accumulation of H1 zero in differentiating HL-60 cells accompanied by only a slight decline in cell proliferation; this agrees with the idea that H1 zero expression is not directly associated with the inhibition of cell growth. Rather higher expression of H1 zero is related to changes during cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7758147     DOI: 10.1002/cbf.290130209

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  8 in total

1.  Reactive oxygen species regulate the differentiation of acute promyelocytic leukemia cells through HMGB1-mediated autophagy.

Authors:  Liangchun Yang; Wenwen Chai; Yanping Wang; Lizhi Cao; Min Xie; Minghua Yang; Rui Kang; Yan Yu
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

2.  Photopolymerization with EDTA and Riboflavin for Proteins Analysis in Polyacrylamide Gel Electrophoresis.

Authors:  Volodymyr Shlyakhovenko; Olena Samoylenko
Journal:  Protein J       Date:  2022-07-27       Impact factor: 4.000

3.  Characterization and Quantification of Oxidized High Mobility Group Box 1 Proteoforms Secreted from Hepatocytes by Toxic Levels of Acetaminophen.

Authors:  Ross Pirnie; Kevin P Gillespie; Liwei Weng; Clementina Mesaros; Ian A Blair
Journal:  Chem Res Toxicol       Date:  2022-08-03       Impact factor: 3.973

4.  High-mobility group box proteins modulate tumor necrosis factor-alpha expression in osteoclastogenesis via a novel deoxyribonucleic acid sequence.

Authors:  Kosj Yamoah; Alina Brebene; Ramkumarie Baliram; Kenji Inagaki; Georgia Dolios; Ario Arabi; Rinosha Majeed; Hitoshi Amano; Rong Wang; Robert Yanagisawa; Etsuko Abe
Journal:  Mol Endocrinol       Date:  2008-01-24

5.  The expression of HMGB1 protein and its receptor RAGE in human malignant tumors.

Authors:  Nora Kostova; Stanislava Zlateva; Iva Ugrinova; Evdokia Pasheva
Journal:  Mol Cell Biochem       Date:  2009-10-30       Impact factor: 3.396

Review 6.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

Review 7.  High Mobility Group Box 1 in Human Cancer.

Authors:  Bernardo L Rapoport; Helen C Steel; Annette J Theron; Liezl Heyman; Teresa Smit; Yastira Ramdas; Ronald Anderson
Journal:  Cells       Date:  2020-07-10       Impact factor: 6.600

Review 8.  The dual role and therapeutic potential of high-mobility group box 1 in cancer.

Authors:  Si-Jia He; Jin Cheng; Xiao Feng; Yang Yu; Ling Tian; Qian Huang
Journal:  Oncotarget       Date:  2017-05-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.